FindTrial
Sign In

Prospective study of Molecular Adsorbents Recirculating System (MARS) therapy in chronic stable hepatic dysfunction

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN27485179
Enrollment
Unknown
Registered
2004-09-30
Start date
2004-03-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic alcoholic liver disease Digestive System Alcoholic liver disease

Interventions

Patients with stable chronic alcoholic liver disease currently abstinent will be recruited from hepatology out-patient clinics. They will be randomised to a control non-treatment group or to MARS ther

Sponsors

Record Provided by the NHSTCT Register - 2004 Update - Department of Health (UK)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with stable alcoholic liver disease who are currently abstinent from alcohol.

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

MeasureTime frame
1. Quality of life and symptom load 2. Level of hepatic encephalopathy and biochemical parameters 3. Level of portal hypertension and systemic haemodynamics—

Secondary

MeasureTime frame
Not provided at time of registration—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026